Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Authors:
- 1 October 1989
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (4) , 749-756
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988
- Cigarette Smoking and Risk of Stroke in Middle-Aged WomenNew England Journal of Medicine, 1988
- An Overview of the British and American Aspirin StudiesNew England Journal of Medicine, 1988
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978